Correlation of angiogenesis biomarkers with early metastatic progression in NSCLC as determined using a multiplexed immunoassay kit

Brought to you by:

First Name *

Last Name *

Email *

Phone Number *

Company *

Company Address *

City *

Country *

State/Province *

Postal Code *

Job Title *

Company Size

Industry *

Get the White Paper

FREE White Paper

Correlation of angiogenesis biomarkers with early metastatic progression in NSCLC

Sponsored by EMD Millipore

Dysregulation of angiogenesis, a fundamental process in growth, development and tissue repair, leads to abnormal blood vessel growth involved in many common diseases and plays a significant role in cancer tumor growth and metastasis. We demonstrate the utility of the MILLIPLEX® MAP Human Angiogenesis/Growth Factor Panel , based on the Luminex® xMAP® bead-based multiplexed assay platform, in the analysis of 17 targets involved in the angiogenesis pathway in a cohort of 38 patients with various stages of non-small cell lung cancer (NSCLC).

Privacy Policy

This data may be used by the sponsor to provide you with information within the scope of this white paper. Any information you submit by this form will only be used for the purposes indicated. You can trust Advantage Business Media not to rent, sell, exchange, or give your information to any third party without permission.